
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. All were audited by a statutory auditor.
- 2025not filed
- 202426/06/2025
- 202309/07/2024
- 202205/07/2023
- 202111/07/2022
- 202020/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
News
Industry
- Manufacture of basic chemicals, fertilisers and nitrogen compounds, plastics and synthetic rubber in primary forms (20.1)
Website technology
- Website
- WordPress
Trademarks
The company holds 5 active trademarks registered with the Polish Patent Office. The first mark was filed in 2011.
| Mark | Protected until | |
|---|---|---|
| BAFACAM (word) | Dec 13, 2031 | |
| AmKur Bio (word) | Jun 16, 2031 | |
| Proteon Zdrowie | Jul 2, 2030 | |
| BAFADOR (word) | Feb 25, 2034 | |
| BAFASAL (word) | Jun 16, 2031 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, one member of the management board acting independently is authorized to make declarations of will on behalf of the company. In the case of a management board consisting of two or more members, two members of the management board acting jointly are authorized to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Proteon Animal Nutrition sp. z o.o. | 2,701.24 USD | 100% |
Bank accounts
Was a VAT taxpayer from 2005-06-02 to 2026-09-03.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
5 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Feb 3, 2026 | Petition to declare entrepreneur bankruptcy | Joined | |
| Dec 15, 2025 | Petition to declare entrepreneur bankruptcy | In progress | |
| Jan 26, 2026 | Complaint against a decision in accelerated arrangement proceedings | Closed | |
| Jul 29, 2025 | Accelerated arrangement proceedings | Closed | |
| Jul 2, 2025 | Petition to open accelerated arrangement proceedings | Closed |
MSiG notices
47 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Feb 17, 2026 | Shareholders' meeting convened | |
| Jan 29, 2026 | Shareholders' meeting convened | |
| Nov 27, 2025 | Shareholders' meeting convened | |
| Nov 13, 2025 | Shareholders' meeting convened | |
| Oct 22, 2025 | Shareholders' meeting convened |
Public aid
15 public aid cases recorded, with a total value of $12,464,408.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | PGE Obrót S.A. | |
| Aug 28, 2023 | Regional investment aid | –– | Marszałek Województwa Łódzkiego | |
| Jul 29, 2021 | Aid for SME access to finance — risk finance aid | –– | PFR Ventures sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medapp S.A. | $3,351,163.61 | medapp.pl | ||
| Biotechna S.A. | $2,472,888.07 | bsbiotechna.com | ||
| Read-Gene S.A. | $2,163,474.84 | read-gene.com | ||
| Skinlab P.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc East sp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| Centrum Innowacji I Wdrożeń Bio-Inwest sp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| COS Lab P.S.A. | $1,028,123.83 | coslab.pl | ||
| Syvento sp. z o.o. | $970,435.47 | syvento.com | ||
| WPD Pharmaceuticals sp. z o.o. | $919,175.63 | wpdpharmaceuticals.com | ||
| Uvera S.A. | $504,076.78 | uvera.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-07 | Share capital increase (1,235,884.60 PLN → 1,243,961.60 PLN) | |
| 2024-08-21 | Share capital increase (1,223,775.10 PLN → 1,235,884.60 PLN) | |
| 2024-07-22 | Share capital increase (1,217,916.80 PLN → 1,223,775.10 PLN) | |
| 2024-07-11 | Share capital increase (1,199,407.70 PLN → 1,217,916.80 PLN) | |
| 2023-03-17 | Share capital increase (1,137,869.30 PLN → 1,199,407.70 PLN) |
FAQ
Last updated: 2026-10-07